Apico-coronal Position of Tissue-level Implants Bone Stability
Launched by INTERNATIONAL PIEZOSURGERY ACADEMY · May 2, 2022
Trial Information
Current as of July 09, 2025
Completed
Keywords
ClinConnect Summary
Early marginal bone loss (EMBL) is a non-infective remodeling process of peri-implant crestal bone occurring within the first year after implant insertion. EMBL has a multifactorial etiology, being influenced by various surgical and prosthetic factors, including insufficient crestal width, surgical trauma, biological width formation, microbial colonization of implant-abutment micro-gap, horizontal implant-abutment mismatch ("the platform-switching concept"), the number of abutment connection/disconnections, prosthetic abutment height, design and mechanical stability of implant-abutment conn...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients were partially edentulous and required placement of at least one single delayed implant in pristine bone in the posterior mandible
- • presence of keratinized mucosa with a minimum bucco-lingual width of 3 mm;
- • bone crest with at least 6mm of width and 9 mm of height above the mandibular canal without concomitant or previous bone augmentation procedures;
- • presence of the opposing dentition
- Exclusion Criteria:
- • smokers
- • uncontrolled periodontitis
- • medication consumption for at least 3 months prior to treatment
- • history of head or neck radiation therapy
- • pregnancy or lactating at any time during the study
About International Piezosurgery Academy
The International Piezosurgery Academy (IPA) is a leading organization dedicated to advancing the field of piezosurgery through innovative research, education, and clinical application. With a focus on enhancing surgical techniques and improving patient outcomes, IPA sponsors clinical trials that explore the efficacy and safety of piezoelectric technology in various medical and dental procedures. Committed to fostering collaboration among healthcare professionals, the academy provides comprehensive training programs and resources, positioning itself at the forefront of surgical innovation and excellence in patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Parma, , Italy
Cassano Allo Ionio, Cs, Italy
Patients applied
Trial Officials
Teresa Lombardi, Dr.
Principal Investigator
Hesire dental office
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials